A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1123-1131

  Wagner, Eric F ^a   Hieb, Marija ^a   Hanna, Nazeeh ^a   Sharma, Surendra ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD40 ANTIGEN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN P27; RAPAMYCIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE; CONTROLLED STUDY; GERMINAL CENTER; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TONSIL;

ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTE SUBSETS; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; ENZYME INHIBITORS; G1 PHASE; HUMANS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICROTUBULE-ASSOCIATED PROTEINS; POLYENES; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SIROLIMUS; TONSIL; TUMOR SUPPRESSOR PROTEINS;

EID: 0032146276     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Lipsky, P. E. 1990. The induction of human B-cell activation, proliferation, and differentiation by anti-CD3-stimulated T cells: a model of T cell/B cell collaboration. Res. Immunol. 141:424.
2. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
3. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
4. Cambier, J. C., C. M. Pleiman, and M. R. Clark. 1994. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:457.
5. Galibert, L., N. Burden, B. de Saint-Vis, P. Garrone, C. Van Kooten, J. Banchereau, and F. Rousset. 1995. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 182:77.
6. Liu, Y.-J., C. Barthelemy, O. de Bouteiller, C. Arpin, I. Durand, and J. Banchereau. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 2:239.
7. Arpin, C., J. Banchereau, and Y.-J. Liu. 1997. Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J. Exp. Med. 186:931.
8. DeFrance, T., B. Vanbervliet, J. P. Aubry, and J. Banchereau. 1988. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. J. Exp. Med. 168:1321.
9. Blanchard, D., C. Gaillard, P. Hermann, and J. Banchereau. 1994. Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth. Eur. J. Immunol. 24:330.
10. Kindler, V., and R. H. Zubler. 1997. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 159:2085.
11. Arvanitakis, L., N. Yaseen, and S. Sharma. 1995. Latent membrane protein-1 induces cyclin D2 expression, pRB hyperphosphorylation, and loss of TGFβ1-mediated growth inhibition in EBV-positive B cells. J. Immunol. 155:1047.
12. Tanguay, D. A., and T. C. Chiles. 1996. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156:539.
13. Solvason, N., W. W. Wu, N. Kabra, X. Wu, E. Lees, and M. Howard. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184:407.
14. kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation. J. Immunol. 158:3054.
15. Peter, M., and I. Herskowitz. 1994. Joining the complex: cyclin dependent kinase inhibitory proteins and the cell cycle. Cell 79:181.
16. Hunter, T., and J. Pines. 1994. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79:573.
17. Morgan, D. O. 1995. Principles of cdk regulation. Nature 374:131.
18. Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7:773.
19. 1 cyclins. Cell 73:1059.
20. Ewen, M. 1994. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13:45.
21. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
22. 1 phase of the cell cycle. Cell 65:701.
23. Seto, M., K. Yamamoto, Iida, S., Y. Akao, K. R. Utsumi, I. Kubonishi, I. Miyoshi, T. Ohtsuki, Y. Yawata, M. Namba, T. Motokura, A. Arnold, T. Takahashi, and R. Ueda. 1992. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogens 7:1401.
24. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321.
25. Palmero, I., A. Holder, A. J. Sinclair, C. Dickson, and G. Peters. 1993. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 8:1049.
26. ink4B is a potential effector of TGFβ-induced cell cycle arrest. Nature 371:257.
27. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/cip and ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGFβ. Genes Dev. 9:1831.
28. 1 cyclin-dependent kinases. Cell 75:805.
29. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
30. 1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67.
31. kip1 accumulation during the cell cycle. Science 271:1861.
32. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romano, G. Del Sal, V. Chau, P. R. Yew, G. F. Dreatta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682.
33. 3-mediated gene regulation in human B lymphocytes. J. Biol. Chem. 269:13437.
34. Mond, J. J., and M. Brunswick. 1994. Assays for B cell function. In Current Protocols in Immunology, Vol. 3. J. E. Collgan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, pp. 3.8.11.
35. - germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. Immunity 4:603.
36. Wheeler, K., J. D. Pound, J. Gordon, and R. Jefferis. 1993. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 23:1165.
37. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Roussel. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
38. Galibert, L., I. Durand, J. Banchereau, and F. Roussel. 1994. CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell pool. J. Immunol. 152:22.
39. Nagasawa, M., I. Melamed, A. Kupfer, E. Gelfand, and J. J. Lucas. 1997. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation. J. Immunol. 158:5146.
40. Soos, T. S., H. Kiyokawa, J. Yan, M. Rubin, A. Giordana, A. Deblasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-cdk complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135.
41. Moore, K. W., A. O'Garra, P. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
42. +) B cells to secrete IgG1 and IgG3. J. Exp. Med. 179:757.
43. Itoh, K., and Hirohata, S. 1995. The role of IL-10 in human B cell activation, proliferation, and differentiation. J. Immunol. 154:4341.
44. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2R system: a current overview. Cell 73:5.
45. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570.
46. Jelinek, D. F., J. B. Spawski, and P. E. Lipsky. 1986. The role of interleukin 2 and IFN-γ in human B cell activation, growth and differentiation. Eur. J. Immunol. 144:725.
47. Karray, S., T. DeFrance, H. Merle-Beral, J. Banchereau, P. Debre and P. Galanaud. 1988. Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal cells. J. Exp. Med. 168:85.
48. Taieb, J., M.-T. Auffredou, and A. Vazquez. 1994. B-T cell interactions modulate inhibitory effects of interleukin-4 on human B cell proliferation. Eur. J. Immunol. 24:480.
49. Dumont, F. J., and Q. Su. 1996. Mechanism of action of the immunosuppressant rapamycin. Life Sci. 58:5.
50. Aagaard-Tillery, K. M., and D. F. Jelinek. 1994. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol. 156: 493.
51. Ray, J. E., M. C. Smith, V. Frost, and G. Y. Morga. 1996. Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells. Immunology 87:390.
52. Larson, A. W., and T. W. LeBien. 1994. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL stimulus. J. Immunol. 153:584.
53. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 138:705.
54. 1/S transition of B precursor cells. Int. Immunol. 8:317.
55. 1 arrest by down-regulation of cyclin D3 in T cell hybridomas. J. Exp. Med 182:401.
56. Lucas, J. J., A. Szepesi, J. F. Modiano, J. Domenico, and E. Gelfand. 1995. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. J. Immunol. 154:6275.
57. Hirama, T., and H. P. Koeffler. 1995. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841.
58. kip1) of cyclin-dependent kinase 4 activation. Cell 79:487.